Accord Biopharma Inc recalls IMULDOSA
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of assurance of Sterility:
- Products
-
- IMULDOSA
- Company
- Accord Biopharma Inc
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- 326 vials
- About this recall
- IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.